Depression, coronary events, platelet inhibition, and serotonin reuptake inhibitors.

[1]  E. Topol,et al.  Heterogeneity of platelet aggregation and major surface receptor expression in patients with acute myocardial infarction. , 1998, American heart journal.

[2]  C. Nemeroff,et al.  The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. , 1998, Archives of general psychiatry.

[3]  F. Sallee,et al.  Platelet serotonin transporter in depressed children and adolescents: 3H-paroxetine platelet binding before and after sertraline. , 1998, Journal of the American Academy of Child and Adolescent Psychiatry.

[4]  A. Malafosse,et al.  The effect of clinical outcome on platelet G proteins of major depressed patients , 1998, European Neuropsychopharmacology.

[5]  L. Konopka,et al.  Platelet Cytosolic Calcium Responses to Serotonin in Depressed Patients and Controls: Relationship to Symptomatology and Medication , 1998, Biological Psychiatry.

[6]  R. Pakala,et al.  Effect of serotonin, thromboxane A2, and specific receptor antagonists on vascular smooth muscle cell proliferation. , 1997, Circulation.

[7]  C. Patrono,et al.  Platelet activation and inhibition in unstable coronary syndromes. , 1997, The American journal of cardiology.

[8]  B. Pollock,et al.  Elevated platelet factor 4 and β-thromboglobulin plasma levels in depressed patients with ischemic heart disease , 1997, Biological Psychiatry.

[9]  B. Tabakoff,et al.  Forskolin-stimulated platelet adenylyl cyclase activity is lower in persons with major depression , 1997, Biological Psychiatry.

[10]  C. Nemeroff,et al.  Exaggerated platelet reactivity in major depression. , 1996, The American journal of psychiatry.

[11]  D. Gill.  Depression is also'a risk factor , 1996, BMJ.

[12]  L. Oreland,et al.  Platelet monoamine oxidase activity in patients with winter seasonal affective disorder , 1996, Psychiatry Research.

[13]  B. Leonard,et al.  Further characterization of the inhibition of platelet aggregation by a plasma factor(s) in unmedicated unipolar depressed patients. , 1995, Journal of affective disorders.

[14]  D. Helmeste,et al.  Serotonin uptake inhibitors modulate intracellular Ca2+ mobilization in platelets. , 1995, European journal of pharmacology.

[15]  B. Leonard,et al.  Alteration by a plasma factor(s) of platelet aggregation in unmedicated unipolar depressed patients. , 1994, Journal of affective disorders.

[16]  J. Gaillard,et al.  Adrenaline-induced platelet aggregation in depressed patients and control subjects. , 1993, Neuropsychobiology.

[17]  Warrington Sj.  Clinical implications of the pharmacology of sertraline. , 1991 .

[18]  K. Matthews,et al.  Platelets and coronary heart disease: potential psychophysiologic mechanisms. , 1991, Psychosomatic medicine.

[19]  J. Eidt,et al.  Role of thromboxane and serotonin as mediators in the development of spontaneous alterations in coronary blood flow and neointimal proliferation in canine models with chronic coronary artery stenoses and endothelial injury. , 1991, Journal of the American College of Cardiology.

[20]  P. Vanhoutte.  Platelet‐Derived Serotonin, the Endothelium, and Cardiovascular Disease , 1991, Journal of cardiovascular pharmacology.

[21]  B. Koe.  Preclinical pharmacology of sertraline: a potent and specific inhibitor of serotonin reuptake. , 1990, The Journal of clinical psychiatry.

[22]  D. Ahern,et al.  Biobehavioral variables and mortality or cardiac arrest in the Cardiac Arrhythmia Pilot Study (CAPS). , 1990, The American journal of cardiology.

[23]  J. Butler,et al.  The Platelet Serotonergic System in Depression and Following Sertraline Treatment , 1988, International clinical psychopharmacology.

[24]  D. Williams,et al.  Kinetics of the interaction of sertraline with the human platelet plasma membrane 5-hydroxytryptamine carrier. , 1988, European journal of pharmacology.

[25]  E. Tukiainen,et al.  Decreased uptake of 5-hydroxytryptamine in blood platelets from depressed patients , 1976, Nature.